These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27796433)

  • 1. A novel synthetic medium and expression system for subzero growth and recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
    Sannino F; Giuliani M; Salvatore U; Apuzzo GA; de Pascale D; Fani R; Fondi M; Marino G; Tutino ML; Parrilli E
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):725-734. PubMed ID: 27796433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated recombinant protein production in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Rippa V; Papa R; Giuliani M; Pezzella C; Parrilli E; Tutino ML; Marino G; Duilio A
    Methods Mol Biol; 2012; 824():203-18. PubMed ID: 22160900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant production of a single-chain antibody fragment in Pseudoalteromonas haloplanktis TAC125.
    Giuliani M; Parrilli E; Sannino F; Apuzzo GA; Marino G; Tutino ML
    Appl Microbiol Biotechnol; 2014 Jun; 98(11):4887-95. PubMed ID: 24535258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Recombinant Protein Production in Pseudoalteromonas haloplanktis TAC125: The Case Study of the Full-Length Human CDKL5 Protein.
    Calvanese M; Colarusso A; Lauro C; Parrilli E; Tutino ML
    Methods Mol Biol; 2022; 2406():219-232. PubMed ID: 35089560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
    Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
    N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
    Giuliani M; Parrilli E; Sannino F; Apuzzo G; Marino G; Tutino ML
    Methods Mol Biol; 2015; 1258():243-57. PubMed ID: 25447868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an improved Pseudoalteromonas haloplanktis TAC125 strain for recombinant protein secretion at low temperature.
    Parrilli E; De Vizio D; Cirulli C; Tutino ML
    Microb Cell Fact; 2008 Feb; 7():2. PubMed ID: 18257924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Colarusso A; Lauro C; Calvanese M; Parrilli E; Tutino ML
    Microb Cell Fact; 2022 Oct; 21(1):211. PubMed ID: 36242022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis.
    Vigentini I; Merico A; Tutino ML; Compagno C; Marino G
    J Biotechnol; 2006 Dec; 127(1):141-50. PubMed ID: 16859797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy for the construction of genomic mutants of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Giuliani M; Parrilli E; Pezzella C; Rippa V; Duilio A; Marino G; Tutino ML
    Methods Mol Biol; 2012; 824():219-33. PubMed ID: 22160901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Fondi M; Maida I; Perrin E; Mellera A; Mocali S; Parrilli E; Tutino ML; Liò P; Fani R
    Environ Microbiol; 2015 Mar; 17(3):751-66. PubMed ID: 24889559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effective cold inducible expression system developed in Pseudoalteromonas haloplanktis TAC125.
    Papa R; Rippa V; Sannia G; Marino G; Duilio A
    J Biotechnol; 2007 Jan; 127(2):199-210. PubMed ID: 16959351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant protein production in Antarctic Gram-negative bacteria.
    Duilio A; Tutino ML; Marino G
    Methods Mol Biol; 2004; 267():225-37. PubMed ID: 15269427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of high-copy number plasmids in Pseudoalteromonas haloplanktis TAC125.
    Calvanese M; Balestra C; Colarusso A; Lauro C; Riccardi C; Fondi M; Parrilli E; Tutino ML
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2469-2481. PubMed ID: 36912903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125: a promising micro-organism for the bioremediation of aromatic compounds.
    Papa R; Parrilli E; Sannia G
    J Appl Microbiol; 2009 Jan; 106(1):49-56. PubMed ID: 19120609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cold-active Lip1 lipase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 is a member of a new bacterial lipolytic enzyme family.
    de Pascale D; Cusano AM; Autore F; Parrilli E; di Prisco G; Marino G; Tutino ML
    Extremophiles; 2008 May; 12(3):311-23. PubMed ID: 18437283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic and periplasmic proteomic signatures of exponentially growing cells of the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC125.
    Wilmes B; Kock H; Glagla S; Albrecht D; Voigt B; Markert S; Gardebrecht A; Bode R; Danchin A; Feller G; Hecker M; Schweder T
    Appl Environ Microbiol; 2011 Feb; 77(4):1276-83. PubMed ID: 21183643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the transcription factor responsible for L-malate-dependent regulation in the marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Papa R; Rippa V; Duilio A
    FEMS Microbiol Lett; 2009 Jun; 295(2):177-86. PubMed ID: 19646180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant expression of Toluene o-Xylene Monooxygenase (ToMO) from Pseudomonas stutzeri OX1 in the marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
    Siani L; Papa R; Di Donato A; Sannia G
    J Biotechnol; 2006 Nov; 126(3):334-41. PubMed ID: 16730836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 for physiologic studies and drug discovery.
    Parrilli E; Ricciardelli A; Casillo A; Sannino F; Papa R; Tilotta M; Artini M; Selan L; Corsaro MM; Tutino ML
    Extremophiles; 2016 Mar; 20(2):227-34. PubMed ID: 26847199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.